NCT06885788 Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women：A Multicenter,Stratified Randomized Controlled Trial
| NCT ID | NCT06885788 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanchong Central Hospital |
| Condition | Inguinal Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 466 participants |
| Start Date | 2024-09-20 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 466 participants in total. It began in 2024-09-20 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the clinical effects of uterine round ligament preservation versus resection in laparoscopic inguinal hernia repair in women.The primary outcomes included Time required for patient surgery.The secondary outcomes included Inguinal hernia recurrence,quality of life assessment,Indicators of postoperative recovery,, et al.
Eligibility Criteria
Inclusion Criteria: * ►Age : Female patients over 18 years of age without a childbearing requirement * Diagnosis and basis : Female patients diagnosed with Unilateral inguinal hernia. * agreed to participate in this study and signed the informed consent form. Exclusion Criteria: * ►Combined with severe heart, liver, kidney and other diseases. * pregnant or lactating women. * those with surgical contraindications.
Frequently Asked Questions
Who can join the NCT06885788 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06885788 currently recruiting?
Yes, NCT06885788 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nanchong Central Hospital to inquire about joining.
Where is the NCT06885788 trial being conducted?
This trial is being conducted at Nanchong, China.
Who is sponsoring the NCT06885788 clinical trial?
NCT06885788 is sponsored by Nanchong Central Hospital. The trial plans to enroll 466 participants.